PNC Financial Services Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.2M Sell
476,166
-10,105
-2% -$1.33M 0.03% 285
2026
Q1
$67.8M Buy
486,271
+12,166
+3% +$1.7M 0.04% 253
2025
Q4
$58.2M Buy
474,105
+53,135
+13% +$6.46M 0.03% 265
2025
Q3
$46.7M Buy
420,970
+4,834
+1% +$549K 0.03% 292
2025
Q2
$46.1M Buy
416,136
+8,023
+2% +$854K 0.03% 287
2025
Q1
$45.7M Buy
408,113
+14,312
+4% +$1.48M 0.02% 282
2024
Q4
$36.4M Buy
393,801
+3,626
+0.9% +$326K 0.02% 302
2024
Q3
$32.7M Buy
390,175
+27,283
+8% +$2.08M 0.02% 321
2024
Q2
$24.9M Sell
362,892
-3,783
-1% -$252K 0.02% 341
2024
Q1
$26.9M Sell
366,675
-11,193
-3% -$861K 0.02% 342
2023
Q4
$30.6M Buy
377,868
+4,745
+1% +$369K 0.02% 316
2023
Q3
$28M Sell
373,123
-659
-0.2% -$50.7K 0.02% 312
2023
Q2
$28.8M Sell
373,782
-9,142
-2% -$729K 0.02% 324
2023
Q1
$31.8M Sell
382,924
-15,643
-4% -$1.3M 0.03% 303
2022
Q4
$34.2M Sell
398,567
-9,315
-2% -$738K 0.03% 291
2022
Q3
$25.2M Buy
407,882
+4,901
+1% +$309K 0.03% 330
2022
Q2
$24.9M Sell
402,981
-13,223
-3% -$819K 0.02% 340
2022
Q1
$24.7M Sell
416,204
-20,651
-5% -$1.32M 0.02% 358
2021
Q4
$31.7M Buy
436,855
+21,813
+5% +$1.5M 0.03% 334
2021
Q3
$29M Sell
415,042
-3,783
-0.9% -$266K 0.03% 338
2021
Q2
$28.8M Sell
418,825
-1,900
-0.5% -$127K 0.03% 345
2021
Q1
$27.2M Sell
420,725
-147
-0% -$9.48K 0.03% 341
2020
Q4
$24.5M Buy
420,872
+33,983
+9% +$2.05M 0.02% 339
2020
Q3
$24.4M Sell
386,889
-1,076
-0.3% -$74.6K 0.03% 329
2020
Q2
$29.8M Sell
387,965
-18,501
-5% -$1.42M 0.04% 290
2020
Q1
$30.4M Buy
406,466
+12,262
+3% +$847K 0.04% 267
2019
Q4
$25.6M Sell
394,204
-24,541
-6% -$1.6M 0.03% 322
2019
Q3
$26.5M Buy
418,745
+32,629
+8% +$2.13M 0.03% 315
2019
Q2
$26.1M Sell
386,116
-23,054
-6% -$1.52M 0.03% 325
2019
Q1
$26.6M Buy
409,170
+6,633
+2% +$441K 0.03% 335
2018
Q4
$25.2M Sell
402,537
-80,252
-17% -$5.61M 0.03% 322
2018
Q3
$37.3M Sell
482,789
-47,512
-9% -$3.59M 0.04% 295
2018
Q2
$37.6M Sell
530,301
-22,739
-4% -$1.61M 0.04% 295
2018
Q1
$41.7M Buy
553,040
+5,038
+0.9% +$400K 0.04% 273
2017
Q4
$39.3M Sell
548,002
-102,864
-16% -$7.81M 0.04% 289
2017
Q3
$52.7M Buy
650,866
+47,859
+8% +$3.66M 0.05% 241
2017
Q2
$42.7M Sell
603,007
-47,092
-7% -$3.13M 0.05% 280
2017
Q1
$44.2M Sell
650,099
-71,829
-10% -$5.05M 0.05% 270
2016
Q4
$51.7M Sell
721,928
-188,504
-21% -$14M 0.06% 241
2016
Q3
$72M Sell
910,432
-845,375
-48% -$68.7M 0.08% 189
2016
Q2
$146M Sell
1,755,807
-59,053
-3% -$5.24M 0.17% 120
2016
Q1
$167M Buy
1,814,860
+55,175
+3% +$4.98M 0.19% 107
2015
Q4
$178M Sell
1,759,685
-25,314
-1% -$2.63M 0.21% 100
2015
Q3
$175M Buy
1,784,999
+738,810
+71% +$82.1M 0.21% 98
2015
Q2
$122M Sell
1,046,189
-21,702
-2% -$2.37M 0.14% 143
2015
Q1
$105M Sell
1,067,891
-906,694
-46% -$92.1M 0.12% 157
2014
Q4
$186M Buy
1,974,585
+42,678
+2% +$4.41M 0.2% 90
2014
Q3
$206M Buy
1,931,907
+523,288
+37% +$51.2M 0.24% 78
2014
Q2
$117M Buy
1,408,619
+840,218
+148% +$65.4M 0.15% 118
2014
Q1
$40.3M Buy
568,401
+20,042
+4% +$1.57M 0.05% 232
2013
Q4
$41.2M Sell
548,359
-82,038
-13% -$5.71M 0.05% 227
2013
Q3
$39.6M Buy
630,397
+5,185
+0.8% +$310K 0.06% 221
2013
Q2
$32.1M Buy
+625,212
New +$32.6M 0.05% 242

Other funds holding GILD

PNC Financial Services Group's GILD Position: Q2 2026 in Review

PNC Financial Services Group reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $1.33M and leaving 476,166 shares worth $60.2M. The position accounts for 0.03% of the portfolio, ranked #285.

PNC Financial Services Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $206M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • PNC Financial Services Group held 476,166 shares of Gilead Sciences worth $60.2M as of Q2 2026.
  • PNC Financial Services Group sold 10,105 Gilead Sciences shares in Q2 2026, an estimated $1.33M.
  • Gilead Sciences made up 0.03% of PNC Financial Services Group's portfolio in Q2 2026, its #285 holding.
  • PNC Financial Services Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Gilead Sciences position peaked at $206M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.